Sanjay Trehan

Mr. Sanjay Trehan is the SVP of Business Development of 858 Therapeutics. Sanjay joined 858 Therapeutics from Genentech, where he served as Business Development Project Leader and led the evaluation and execution of multiple drug discovery collaborations, including partnerships with Ribometrix and Atalanta Therapeutics. Prior to joining Genentech, he held business development roles of increasing responsibility at Sanofi Genzyme, including Director and Head of Business Development and Licensing for Rare Diseases. During his time at Sanofi, Mr. Trehan successfully led numerous transactions, including product licenses, co-developments, co-promotions, drug discovery collaborations and strategic alliances.

Sanjay received a B.S. in Computational Biology from Brown University and an M.B.A. from the MIT Sloan School of Management.